Changeflow GovPing Healthcare ONKOREPLICA Trademark - Oncology Diagnostics
Routine Notice Added Final

ONKOREPLICA Trademark - Oncology Diagnostics

Favicon for changeflow.com USPTO Trademarks - Medical Services (Class 044)
Published
Detected
Email

Summary

USPTO published trademark application TM79437761 for "ONKOREPLICA" covering medical diagnostic services for oncology using live cell preparations, medical and pharmacological research services using in vitro analysis of cellular responses, and biological preparations containing live cells for scientific research. The trademark covers international class 044 (medical services) and class 001 (chemical preparations).

What changed

USPTO published trademark application TM79437761 for ONKOREPLICA on April 2, 2026. The application covers three distinct goods/service categories: (1) medical diagnostic services for disease identification and personalized treatment planning using live cell preparations, (2) medical and pharmacological research services involving in vitro analysis of cellular responses to pharmaceutical substances, and (3) biological preparations containing live cells for scientific research and laboratory use.

The publication initiates a 30-day opposition period during which third parties may file an opposition if they believe registration would damage their existing trademark rights. Companies offering oncology diagnostics, live cell analysis services, or related biological preparations should review whether their existing trademarks could conflict with ONKOREPLICA before the opposition deadline. No specific compliance actions are required by this publication itself.

Archived snapshot

Apr 3, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

ONKOREPLICA

Published for Opposition TM79437761 Kind: published Apr 02, 2026

Abstract

Medical diagnostic services for disease identification and personalized treatment planning that use live cell preparations to assess patient-specific cellular responses.; Medical and pharmacological research services, namely in vitro analysis of cellular responses to pharmaceutical substances using biological preparations containing live cells; providing analytical reports and data interpretation for medical and pharmacological research and development purposes.; Biological preparations containing live cells for scientific research and laboratory use, namely cell cultures and cellular compositions for analyzing pharmaceutical effects on cellular behavior in vitro.

Filing Date

2025-10-08

View original document →

Get daily alerts for USPTO Trademarks - Medical Services (Class 044)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79437761

Who this affects

Applies to
Drug manufacturers Healthcare providers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 6211 Healthcare Providers 3345 Medical Device Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Biotechnology

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!